Agios Pharmaceuticals Stock Quote AGIO - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

32.36

Bid

32.37

Ask

32.44

Volume

159,229

32.31 Day's Range 33.80

20.96 52 Week Range 62.58

Market Cap

1.845B

Previous Close

33.40

Open

33.29

Last Trade

32.42

Last Trade Time

12:42:30

Financial Volume

$ 5,208,072

VWAP

32.7081

Average Volume (3m)

785,718

Shares Outstanding

57,030,195

Dividend Yield

PE Ratio

-5.24

Earnings Per Share (EPS)

-6.17

Revenue

26.82M

Net Profit

-352.09M

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' p... Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.agios.com

Headquarters

Wilmington, Delaware, USA

Founded

Agios Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AGIO. The last closing price for Agios Pharmaceuticals was $33.40. Over the last year, Agios Pharmaceuticals shares have traded in a share price range of $ 20.96 to $ 62.58.

Agios Pharmaceuticals currently has 57,030,195 shares outstanding. The market capitalization of Agios Pharmaceuticals is $1.90 billion. Agios Pharmaceuticals has a price to earnings ratio (PE ratio) of -5.24.

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease

CAMBRIDGE, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare...

Form 4 - Statement of changes in beneficial ownership of securities

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat

– ENERGIZE-T Study Achieved Primary and All Key Secondary Endpoints in Adult Patients with Transfusion-Dependent Alpha- or Beta-Thalassemia – – ENERGIZE-T is First Phase 3 Study to Demonstrate...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition

– Results from Phase 3 ENERGIZE-T Study of Mitapivat in Transfusion-dependent Thalassemia will be Presented in Oral Session – – Tebapivat Phase 1 Data in Sickle Cell Disease and Phase 2b...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-3.06	-8.63918690006	35.42	35.6	32.31	671291	34.33991354	CS
4	-27.04	-45.5218855219	59.4	62.45	32.31	1209283	43.04460225	CS
12	-8.8	-21.3799805637	41.16	62.58	32.31	785718	47.07206599	CS
26	-10.78	-24.9884098285	43.14	62.58	32.31	637508	46.33793541	CS
52	10.16	45.7657657658	22.2	62.58	20.96	730695	38.36130492	CS
156	-1.31	-3.8907038907	33.67	62.58	16.75	614678	30.82785757	CS
260	-15.87	-32.904831018	48.23	62.58	16.75	643271	37.33682747	CS

AGIO - Frequently Asked Questions (FAQ)

What is the current Agios Pharmaceuticals share price?

The current share price of Agios Pharmaceuticals is $ 32.36

How many Agios Pharmaceuticals shares are in issue?

Agios Pharmaceuticals has 57,030,195 shares in issue

What is the market cap of Agios Pharmaceuticals?

The market capitalisation of Agios Pharmaceuticals is USD 1.9B

What is the 1 year trading range for Agios Pharmaceuticals share price?

Agios Pharmaceuticals has traded in the range of $ 20.96 to $ 62.58 during the past year

What is the PE ratio of Agios Pharmaceuticals?

The price to earnings ratio of Agios Pharmaceuticals is -5.24

What is the cash to sales ratio of Agios Pharmaceuticals?

The cash to sales ratio of Agios Pharmaceuticals is 68.72

What is the reporting currency for Agios Pharmaceuticals?

Agios Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Agios Pharmaceuticals?

The latest annual turnover of Agios Pharmaceuticals is USD 26.82M

What is the latest annual profit for Agios Pharmaceuticals?

The latest annual profit of Agios Pharmaceuticals is USD -352.09M

What is the registered address of Agios Pharmaceuticals?

The registered address for Agios Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Agios Pharmaceuticals website address?

The website address for Agios Pharmaceuticals is www.agios.com

Which industry sector does Agios Pharmaceuticals operate in?

Agios Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Symbol	Price	Vol.
NXUNXU Inc	$ 1.98 (713.48%)	456.34M
WATTEnergous Corporation	$ 1.538 (274.03%)	167.83M
INTZIntrusion Inc	$ 5.485 (153.94%)	115.21M
JDZGJIADE Ltd	$ 1.51 (115.65%)	7.54M
CYNCYNGN Inc	$ 1.205 (91.91%)	62.14M
ABPAbpro Holdings Inc	$ 2.1215 (-52.75%)	1.52M
TRAWTraws Pharma Inc	$ 7.77 (-42.10%)	907.82k
SHOTWSafety Shot Inc	$ 0.122005 (-32.33%)	1.1k
LITMSnow Lake Resources Ltd	$ 1.155 (-27.81%)	45.08M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF	$ 66.74 (-24.56%)	9.05k
NXUNXU Inc	$ 1.98 (713.48%)	456.34M
VINCVincerx Inc	$ 0.3288 (69.48%)	305.17M
XTIAXTI Aerospace Inc	$ 0.0399 (1.01%)	185.44M
WATTEnergous Corporation	$ 1.535 (273.30%)	167.84M
SMXSMX Security Matters Public Company	$ 0.621201 (75.68%)	153.31M

Symbol

Price

Vol.

NXUNXU Inc

$ 1.98

(713.48%)

456.34M

VINCVincerx Inc

$ 0.3288

(69.48%)

305.17M

XTIAXTI Aerospace Inc

$ 0.0399

(1.01%)

185.44M

WATTEnergous Corporation

$ 1.535

(273.30%)

167.84M

SMXSMX Security Matters Public Company

$ 0.621201

(75.68%)

153.31M

$AGIO DD Notes ~ http://www.ddnotesmaker.com/AGIO

Topdown market analysis:
Market is _BULLISH_
Today is _UP_
Bullish Sector _BIOTECHNOLOGY_

bullish stock in this sector

$AGIO recent news/filings

## source: finance.yahoo.com

Wed, 29 Oct 2014 17:41:34 GMT ~ Nasdaq stocks posting largest percentage increases

read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220237991--finance.html
*********************************************************

Wed, 29 Oct 2014 10:00:00 GMT ~ 'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals

read full: http://www.thestreet.com/story/12861472/1/mad-money-lightning-round-im-sticking-with-isis-pharmaceuticals.html?puc=yahoo&cm_ven=YAHOO
*********************************************************

Tue, 28 Oct 2014 23:24:10 GMT ~ Lightning Round: GNC, Goldman and more

read full: http://www.cnbc.com/id/102128707?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=102128707
*********************************************************

Tue, 28 Oct 2014 18:12:59 GMT ~ Two biotech leaders to watch

read full: http://www.marketwatch.com/News/Story/Story.aspx?guid=D7CCEB70-396E-49E4-BD03-2CB82C69AFAC&siteid=yhoof2
*********************************************************

Mon, 27 Oct 2014 13:11:41 GMT ~ Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014

[at noodls] - CAMBRIDGE, Mass., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced that ...

read full: http://www.noodls.com/view/A2EF8BBB5ACD70924BD84BBCAE0F2381B1BCF76C
*********************************************************

$AGIO charts

basic chart ## source: stockcharts.com

basic chart ## source: stockscores.com

big daily chart ## source: stockcharts.com

big weekly chart ## source: stockcharts.com

$AGIO company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/AGIO/company-info
Ticker: $AGIO
OTC Market Place: Not Available
CIK code: not found
Company name: Agios Pharmaceuticals, Inc.
Incorporated In:

Business Description:

http://www.agios.com/

Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. Its product candidates include AG-221, an oral inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein for the treatment of patients with cancers that harbor IDH2 mutations, as well as for the Type II D-2 hydroxyglutaric aciduria treatment; and AG-120, an oral inhibitor of the mutated IDH1 protein for the treatment of patients with cancers that harbor IDH1 mutations. The company is also developing AG-348, an oral small molecule activator of PKR enzyme for the treatment of patients with pyruvate kinase deficiency. It has a collaboration agreement with Celgene Corporation to discover, develop, and commercialize disease-altering therapies in oncology. Agios Pharmaceuticals, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.

$AGIO share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$AGIO extra dd links

Company name: Agios Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AGIO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AGIO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AGIO+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/news - http://finance.yahoo.com/q/h?s=AGIO+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AGIO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AGIO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AGIO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Agios+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Agios+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Agios+Pharmaceuticals%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AGIO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AGIO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AGIO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AGIO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AGIO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AGIO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AGIO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AGIO+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AGIO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AGIO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AGIO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AGIO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AGIO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AGIO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AGIO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AGIO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AGIO

$AGIO DD Notes ~ http://www.ddnotesmaker.com/AGIO

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Agios Pharmaceuticals Inc (AGIO) Quote

Agios Pharmaceuticals Inc (AGIO)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About Agios Pharmaceuticals Inc

Ask ADVFN Intelligence (AI)

AGIO Latest News

AGIO - Frequently Asked Questions (FAQ)

Movers

AGIO Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free